Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.074x

Based on the latest financial reports, Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has a cash flow conversion efficiency ratio of 0.074x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥502.01 Million ≈ $73.46 Million USD) by net assets (CN¥6.75 Billion ≈ $987.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Nanjing King-friend Biochemical Pharmace (603707) total market value for the company's overall valuation and market capitalisation.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanjing King-friend Biochemical Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 603707 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Monadelphous Group Ltd F:8MP	0.043x
H&R Real Estate Investment Trust TO:HR-UN	0.007x
Westone Information Industry Inc SHE:002268	-0.033x
Ningbo PIA Automation Holding Corp. A SHG:688306	N/A
Shaanxi Ligeance Mineral Resources Co Ltd SHE:000697	0.002x
ZAI LAB LTD0000006 F:1ZLB	-0.018x
Kumho Petro Chemical KO:011780	0.001x
Hunan Aihua Group Co Ltd SHG:603989	0.025x

Annual Cash Flow Conversion Efficiency for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Nanjing King-friend Biochemical Pharmaceutical Co Ltd from 2013 to 2025. View Nanjing King-friend Biochemical Pharmace stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.90 Billion ≈ $1.01 Billion	CN¥1.18 Billion ≈ $173.08 Million	0.171x	-25.91%
2024-12-31	CN¥6.49 Billion ≈ $949.42 Million	CN¥1.50 Billion ≈ $219.68 Million	0.231x	-17.14%
2023-12-31	CN¥5.80 Billion ≈ $848.50 Million	CN¥1.62 Billion ≈ $236.94 Million	0.279x	+189.21%
2022-12-31	CN¥6.17 Billion ≈ $902.45 Million	CN¥595.45 Million ≈ $87.13 Million	0.097x	-23.70%
2021-12-31	CN¥5.40 Billion ≈ $790.59 Million	CN¥683.63 Million ≈ $100.04 Million	0.127x	+183.74%
2020-12-31	CN¥3.74 Billion ≈ $547.95 Million	CN¥-565.85 Million ≈ $-82.80 Million	-0.151x	+46.05%
2019-12-31	CN¥3.00 Billion ≈ $439.59 Million	CN¥-841.38 Million ≈ $-123.12 Million	-0.280x	-1187.25%
2018-12-31	CN¥2.42 Billion ≈ $354.28 Million	CN¥62.37 Million ≈ $9.13 Million	0.026x	+122.54%
2017-12-31	CN¥2.05 Billion ≈ $300.31 Million	CN¥-234.59 Million ≈ $-34.33 Million	-0.114x	+47.60%
2016-12-31	CN¥1.31 Billion ≈ $192.37 Million	CN¥-286.79 Million ≈ $-41.97 Million	-0.218x	-273.64%
2015-12-31	CN¥1.09 Billion ≈ $159.89 Million	CN¥137.28 Million ≈ $20.09 Million	0.126x	-27.47%
2014-12-31	CN¥1.03 Billion ≈ $150.99 Million	CN¥178.74 Million ≈ $26.16 Million	0.173x	-9.03%
2013-12-31	CN¥1.02 Billion ≈ $149.02 Million	CN¥193.91 Million ≈ $28.38 Million	0.190x	--

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

SHG:603707 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.82 Billion

CN¥12.44 Billion CNY

Market Cap Rank

#6517 Global

#1307 in China

Share Price

CN¥7.70

Change (1 day)

-2.65%

52-Week Range

CN¥6.84 - CN¥10.47

All Time High

CN¥33.62